China approves first domestic Covid-19 vaccine for general use
Sinopharm claims 79% efficacy but concerns remain over lack of trial data transparency
Full Article
China approves first domestic Covid-19 vaccine for general use
FT.com
0 shares
1 views
You might like
Related news coverage
2021: Build Back To The Future
Eurasia Review
By Jorge Valero
(EurActiv) -- The EU will double down on its efforts to use the Covid-19 crisis to accelerate the..
Advertisement
More coverage
China OKs 1st homegrown vaccine as COVID surges globally
Newsday
China has approved its first homegrown COVID-19 vaccine for general use, health regulators said Thursday, marking the addition of..